TriSalus Life Sciences, Inc. (TLSI): debt financing — TriSalus draws $10M under senior secured credit facility; issues warrants for 91,263 shares

TriSalus Life Sciences, Inc.

Closed Second Tranche of $50M credit facility, receiving $10M on Feb 18, 2025.
Loan maturity date is April 30, 2029.
Issued warrants to OrbiMed to purchase 91,263 shares at $5.4787 per share.
Warrants have a 7-year term and contain customary share/price adjustment provisions.
Third Tranche of up to $15M remains available until Dec 31, 2025 subject to revenue conditions.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

TriSalus Life Sciences, Inc. incurred term loan of $10 million with OrbiMed Royalty & Credit Opportunities IV, LP maturing April 30, 2029.

Instrument: term loan
Principal: $10 million
Counterparty: OrbiMed Royalty & Credit Opportunities IV, LP
Maturity: April 30, 2029
Event: incurrence

Exact text from the filing

y ”) and TriSalus Operating Life Sciences, Inc., a Delaware corporation and wholly owned subsidiary of the Company (the “ Borrower ”) entered into a Credit Agreement (the “ Credit Agreement ”), by and between the Company, as parent, the Borrower, as borrower, OrbiMed Royalty & Credit Opportunities IV, LP, a Delaware limited partnership (the “ Initial Lender ”), as a lender, each other lender that may from time to time become a party thereto, and OrbiMed Royalty & Credit Opportunities IV, LP, as administrative agent for the lenders.

View on SEC.gov

102 debt financings filed in the last 30 days. Browse all debt financings →

TriSalus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001826667-25-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.